Furthermore, CD8+ cells gradually increased the level of immunostimulatory cytokines, such as IL-2 and INF-γ, while also reducing CD25+ expression and CD25+FoxP3+ the proportion of Tregs, as well as lowering IL-10 and TGF-β in tumor sites (97). This evidence concerns the gene CD8A and neoplasm.